ARS Pharmaceuticals News - SPRY

Company Name	Stock Ticker Symbol	Market	Type
ARS Pharmaceuticals Inc	SPRY	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.21	-2.54%	8.05	10:25:55

Open Price	Low Price	High Price	Close Price	Prev Close
8.09	7.66	8.13		8.26

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/03/2024	09:01	GLOBE	ARS Pharmaceuticals Submits Response to FDA Complete..
3/21/2024	16:05	GLOBE	ARS Pharmaceuticals Provides Business Update and Reports..
3/07/2024	16:05	GLOBE	ARS Pharmaceuticals Reviews Recent Clinical Updates and..
3/07/2024	12:56	EDGAR2	Form 8-K - Current report
3/06/2024	09:01	GLOBE	ARS Pharmaceuticals to Participate in the Leerink Partners..
3/01/2024	20:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/28/2024	21:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/26/2024	12:08	EDGAR2	Form 144 - Report of proposed sale of securities
2/26/2024	09:01	GLOBE	ARS Pharmaceuticals announces neffy® meets primary endpoints..
2/22/2024	09:01	GLOBE	ARS Pharmaceuticals to Host Virtual neffy® Investor Day on..
2/20/2024	09:01	GLOBE	ARS Pharma Announces Favorable Topline Results from Repeat..
2/05/2024	09:01	GLOBE	ARS Pharmaceuticals to Present Positive Clinical Efficacy..
1/04/2024	16:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/04/2024	16:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/04/2024	16:41	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/04/2024	16:39	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/09/2023	16:02	EDGAR2	Form 8-K - Current report
11/09/2023	16:00	GLOBE	ARS Pharmaceuticals Reports Third Quarter 2023 Financial..
11/09/2023	11:02	GLOBE	ARS Pharmaceuticals Announces Presentation of Clinical Data..
10/06/2023	09:57	DJN	ARS Pharmaceuticals to Meet With FDA on Neffy Rejection
10/06/2023	09:03	GLOBE	ARS Pharmaceuticals Announces Scheduling of a Type A Meeting..
10/03/2023	09:03	GLOBE	Single and Repeat Dose Clinical Study of neffy (epinephrine..
9/25/2023	16:17	EDGAR2	Form 8-K - Current report
9/20/2023	10:20	DJN	ARS Pharmaceuticals Shares Sink to New Lows on FDA Neffy..
9/20/2023	06:30	DJN	ARS Pharmaceuticals Shares Sink Premarket as FDA Rejects..
9/20/2023	06:05	EDGAR2	Form 8-K - Current report
9/19/2023	22:49	GLOBE	FDA Issues Complete Response Letter for neffy® (epinephrine..
9/01/2023	16:15	EDGAR2	Form SC 13D/A - General statement of acquisition of..
8/10/2023	16:08	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	16:05	EDGAR2	Form 8-K - Current report
8/10/2023	16:00	GLOBE	ARS Reports Second Quarter 2023 Financial Results and..
6/28/2023	21:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/28/2023	21:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/28/2023	16:32	EDGAR2	Form 8-K - Current report
6/20/2023	08:00	GLOBE	ARS Pharmaceuticals Announces PDUFA Date Extension for..
5/15/2023	09:00	GLOBE	ARS Pharmaceuticals Highlights Progress and Reports First..
5/12/2023	08:55	DJN	ARS Pharmaceuticals Soar 68% in Premarket Trading as FDA..
5/11/2023	19:01	GLOBE	FDA Advisory Committee Votes in Support of Favorable..
5/09/2023	09:10	GLOBE	ARS Pharmaceuticals Announces Availability of Briefing..